España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Can Fite Biofarma
CANF
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.48
0.04
2.78%
At close: -
Get Report
Comment
Can Fite Biofarma (CANF) Forecast
News
Earnings
Can Fite Biofarma (CANF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Can Fite Biofarma (AMEX:CANF) Stock
Can Fite Biofarma Stock (AMEX: CANF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 12, 2024
Can-Fite Biopharma Has Received A Notice Of A...
Benzinga Newsdesk
Thursday, December 05, 2024
D. Boral Capital Maintains Buy on Can Fite Bi...
Benzinga Newsdesk
Wednesday, December 04, 2024
Can-Fite BioPharma Announced 8 Years Survival...
Benzinga Newsdesk
Tuesday, November 12, 2024
HC Wainwright & Co. Reiterates Buy on Can Fit...
Benzinga Newsdesk
Monday, November 11, 2024
Can-Fite Biopharma Has Started Dosing Of The ...
Benzinga Newsdesk
Monday, November 04, 2024
Can-Fite's Snti-Obesity Drug Namodenoson Rece...
Benzinga Newsdesk
Thursday, October 10, 2024
EF Hutton Maintains Buy on Can Fite Biofarma,...
Benzinga Newsdesk
Wednesday, October 09, 2024
Can-Fite Biopharma shares are trading higher ...
Benzinga Newsdesk
The FDA Has Granted Orphan Drug Designation T...
Benzinga Newsdesk
Tuesday, October 08, 2024
Can-Fite BioPharma Designated Orphan Designat...
Benzinga Newsdesk
Tuesday, September 24, 2024
EF Hutton Maintains Buy on Can Fite Biofarma,...
Benzinga Newsdesk
Monday, September 16, 2024
Israeli Ministry Of Health Approves Can-Fite ...
Benzinga Newsdesk
Friday, August 30, 2024
EF Hutton Maintains Buy on Can Fite Biofarma,...
Benzinga Newsdesk
Thursday, August 29, 2024
Can-Fite BioPharma shares are trading higher....
Benzinga Newsdesk
Can-Fite BioPharma 1H EPS $(0.00), Same YoY; ...
Benzinga Newsdesk
Wednesday, July 17, 2024
EF Hutton Initiates Coverage On Can Fite Biof...
Benzinga Newsdesk
Thursday, July 11, 2024
Can-Fite Submits Application To FDA For Orpha...
Benzinga Newsdesk
Monday, July 01, 2024
Can-Fite Biopharma Announced That A Patient W...
Benzinga Newsdesk
Friday, June 28, 2024
Can-fite Biopharma Says Its Veterinary Partne...
Benzinga Newsdesk
Monday, June 24, 2024
Can-Fite Announces New Findings on Namodenoso...
Benzinga Newsdesk
Friday, June 14, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, June 05, 2024
Can-Fite Biopharma Says Its Phase 3 Study For...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Can Fit...
Benzinga Newsdesk
The FDA Has Granted Investigational New Drug ...
Benzinga Newsdesk
Monday, May 06, 2024
Can-Fite Received Notice of Allowance from th...
Benzinga Newsdesk
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Can-Fite Biopharma Announced It Published An ...
Benzinga Newsdesk
Monday, April 15, 2024
Can-Fite's Namodenoson Featured in Biomedicin...
Benzinga Newsdesk
Wednesday, April 03, 2024
Can-Fite BioPharma Submits FDA with an IND Ap...
Benzinga Newsdesk
Thursday, March 28, 2024
Can Fite Biofarma: Q4 Earnings Insights
Benzinga Insights
Can Fite Biofarma FY GAAP EPS $(0.01), Same Y...
Benzinga Newsdesk
Wednesday, February 28, 2024
Can-Fite BioPharma Announced Notice Of Allowa...
Charles Gross
Tuesday, January 30, 2024
Can-Fite Expands the Out-Licensing Deal with ...
Benzinga Newsdesk
Wednesday, December 20, 2023
Can-Fite's Latest Innovation: Namodenoson Sho...
Benzinga Newsdesk
Monday, December 18, 2023
Can-Fite Receives Positive Response From FDA ...
Benzinga Newsdesk
Monday, December 04, 2023
Can-Fite Biopharma Has Completed The Design O...
Benzinga Newsdesk
Thursday, November 30, 2023
Recap: Can Fite Biofarma Q3 Earnings
Benzinga Insights
Can Fite Biofarma 9M Sales $588.00K Down From...
Benzinga Newsdesk
Tuesday, November 21, 2023
Can-Fite Biopharma Ltd Shares Resume Trade
Benzinga Newsdesk
Can-Fite Announces Exercise Of Warrants For A...
Benzinga Newsdesk
Can-Fite Biopharma Shares Halted, News Pendin...
Benzinga Newsdesk
Why Is Liver Cancer Focused Can-Fite BioPharma Stock Trading Higher Today?
Vandana Singh
Can-Fite Says A Patient Who Participated In P...
Benzinga Newsdesk
Thursday, October 26, 2023
Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
Charles Gross
Tuesday, October 24, 2023
Matson To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday
Lisa Levin
HC Wainwright & Co. Maintains Buy on Can Fite...
Benzinga Newsdesk
Monday, October 09, 2023
Can-Fite Signed Recently An Agreement With Fo...
Benzinga Newsdesk
Wednesday, September 27, 2023
Can-Fite Novel Approach for the Treatment of ...
Benzinga Newsdesk
Thursday, August 31, 2023
Can Fite BioPharma H1 EPS $(0.00), Same YoY, ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
